Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline.
作者信息
Januzzi James, Ferreira João Pedro, Böhm Michael, Kaul Sanjay, Wanner Christoph, Brueckmann Martina, Petrie Mark C, Ofstad Anne Pernille, Zeller Cordula, George Jyothis, Fitchett David, Zannad Faiez
机构信息
Cardiology Division, Massachusetts General Hospital, Baim Institute for Clinical Research, Boston, MA, USA.
Centre d'Investigations Cliniques Plurithématique Inserm 1433, Université de Lorraine, Nancy, France.
出版信息
Eur J Heart Fail. 2019 Mar;21(3):386-388. doi: 10.1002/ejhf.1419. Epub 2019 Feb 14.
PMID:30767353
Abstract
摘要
Zotero 插件